Fabien Zoulim
Inserm Unit 271
Hôtel Dieu Hospital
France
Name/email consistency: high
- Quantification and genotyping in management of chronic hepatitis B and C. Zoulim, F. Virus Res. (2002)
- A preliminary benefit-risk assessment of lamivudine for the treatment of chronic hepatitis B virus infection. Zoulim, F. Drug. Saf (2002)
- Assessing hepatitis B virus resistance in vitro and molecular mechanisms of nucleoside resistance. Zoulim, F. Semin. Liver Dis. (2002)
- Detection of hepatitis B virus resistance to antivirals. Zoulim, F. J. Clin. Virol. (2001)
- Evaluation of novel strategies to combat hepatitis B virus targetting wild-type and drug-resistant mutants in experimental models. Zoulim, F. Antivir. Chem. Chemother. (2001)
- Therapy of chronic hepatitis B virus infection: inhibition of the viral polymerase and other antiviral strategies. Zoulim, F. Antiviral Res. (1999)
- Hepatitis C virus infection in special groups. Zoulim, F. J. Hepatol. (1999)
- Drug therapy for chronic hepatitis B: antiviral efficacy and influence of hepatitis B virus polymerase mutations on the outcome of therapy. Zoulim, F., Trépo, C. J. Hepatol. (1998)